MultiplAI Health
Seed Round in 2023
MultiplAI Health specializes in developing advanced blood screening tests aimed at detecting complex diseases, including cardiovascular disorders and cancers. Utilizing RNA sequencing and artificial intelligence, the company analyzes numerous biomarkers in blood samples to facilitate early diagnosis. Their innovative approach allows for universal remote screening, making it possible to conduct tests using simple blood samples that can be administered anywhere, at a significantly lower cost compared to traditional diagnostic methods. This technology not only supports preventative screening for asymptomatic individuals but also aids in post-treatment monitoring, enabling clinicians to make more accurate prognoses and treatment decisions based on enhanced diagnostic stratification.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.